Literature DB >> 9118753

Carcinoid disease: review of the literature.

P C Neary1, P H Redmond, T Houghton, G R Watson, D Bouchier-Hayes.   

Abstract

Carcinoid syndrome is the product of a rare but fascinating malignant neoplasm. Carcinoid syndrome was described more than 100 years ago, and recent advances in diagnostic localization, elucidation of the mechanisms of oncogenesis, treatment options, and, consequently, patient prognosis have been made. Current modalities of treatment, possible therapeutic implications of new avenues of research, and current literature on the chemotherapeutic combinations used are reviewed.

Entities:  

Mesh:

Year:  1997        PMID: 9118753     DOI: 10.1007/bf02050428

Source DB:  PubMed          Journal:  Dis Colon Rectum        ISSN: 0012-3706            Impact factor:   4.585


  5 in total

1.  Surgical resection of hepatic and cardiac neuroendocrine metastases from a caecal primary tumour.

Authors:  J M L Williamson; J Anderson; D R C Spalding
Journal:  Ann R Coll Surg Engl       Date:  2014-03       Impact factor: 1.891

2.  Abdominal angina in patients with a midgut carcinoid, a sign of severe pathology.

Authors:  Harry deVries; Rob T M Wijffels; Pax H B Willemse; René C J Verschueren; Ido P Kema; Arend Karrenbeld; Ted R Prins; Elisabeth G E deVries
Journal:  World J Surg       Date:  2005-09       Impact factor: 3.352

Review 3.  Intra-arterial liver-directed therapies for neuroendocrine hepatic metastases.

Authors:  Sanjay Gupta
Journal:  Semin Intervent Radiol       Date:  2013-03       Impact factor: 1.513

4.  Hepatic artery embolization for control of symptoms, octreotide requirements, and tumor progression in metastatic carcinoid tumors.

Authors:  Scott R Schell; E Ramsay Camp; James G Caridi; Irvin F Hawkins
Journal:  J Gastrointest Surg       Date:  2002 Sep-Oct       Impact factor: 3.452

Review 5.  Diagnostic value of circulating chromogranin a for neuroendocrine tumors: a systematic review and meta-analysis.

Authors:  Xin Yang; Yuan Yang; Zhilu Li; Chen Cheng; Ting Yang; Cheng Wang; Lin Liu; Shengchun Liu
Journal:  PLoS One       Date:  2015-04-20       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.